PEDIATRIC SUSPENSION FORMULATION

Number of patents in Portfolio can not be more than 2000

United States of America

SERIAL NO

17061630

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to storage-stable proton pump inhibitor (PPI) systems comprising a therapeutically effective amount of a PPI or a pharmaceutically acceptable salt thereof, such as omeprazole or a pharmaceutically acceptable salt thereof, which are constituted with water prior to administration. The present disclosure also relates to oral pharmaceutical suspensions comprising water, a therapeutically effective amount of a PPI or a pharmaceutically acceptable salt thereof, such as omeprazole or a pharmaceutically acceptable salt thereof, and one or more buffering agents.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
XEOLAS PHARMACEUTICALS LTDDUBLIN 9

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CLANCY, Maurice Joseph Anthony Dublin, IE 20 584
FLYNN, Damien Patrick Dublin, IE 2 0
MCDAID, Dennis Mark Dublin, IE 2 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation